SCI Pharmtech, Inc. (TPE:4119)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
53.80
-0.80 (-1.47%)
Sep 8, 2026, 1:30 PM CST

SCI Pharmtech Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
60.12107.37534.68294.72308.7855.7
Depreciation & Amortization
256.02252.97233.79145.2990.6163.71
Loss (Gain) From Sale of Assets
---0.581.33-
Loss (Gain) From Sale of Investments
-0.05-1.33-3.621.8714.07-2.24
Loss (Gain) on Equity Investments
58.4746.6323.7313.8412.5613.55
Stock-Based Compensation
---18.72--
Other Operating Activities
-25.93-28.4442.9164.17-22.27-111.43
Change in Accounts Receivable
19.7141.5917.86-133.8-90.59254.77
Change in Inventory
-118.3-107.4-91.36-16.1-219.2586.7
Change in Accounts Payable
-27.382.5114.19-4.3914.86-47.1
Change in Unearned Revenue
29.29-58.8156.566.59-9.99-55.53
Change in Other Net Operating Assets
-28.06-34.7631.79-175.74196.4522.15
Operating Cash Flow
223.89220.32860.52215.77296.57280.28
Operating Cash Flow Growth
-78.44%-74.40%298.82%-27.25%5.81%-71.15%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-398.32-610-946.64-1,029-1,168-771.03
Sale of Property, Plant & Equipment
----0.07-
Sale (Purchase) of Intangibles
-0.09-0.21----3.95
Investment in Securities
17.497.54-62.42163.27156.03237.42
Other Investing Activities
0.8-0.25-0.3-0.112.4-2
Investing Cash Flow
-380.21-512.93-1,009-866.2-1,009-539.56

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-318.5-63112-
Long-Term Debt Issued
-39.83141.79430.81435.77-
Total Debt Issued
811.6358.33141.79493.81547.77-
Short-Term Debt Repaid
---174.9---
Long-Term Debt Repaid
--408.23-28.57-1.89-1.65-1.77
Lease Payments
-6.05-4.8-2.32-1.89-1.65-1.77
Total Debt Repaid
-643.79-408.23-203.47-1.89-1.65-1.77
Net Debt Issued (Repaid)
167.81-49.9-61.68491.91546.12-1.77
Issuance of Common Stock
---957.6--
Common Dividends Paid
-179.26-179.26-149.39-23.85--39.74
Other Financing Activities
-0.080.010.23-1-
Financing Cash Flow
-11.53-229.15-210.841,426547.12-41.52

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-167.86-521.76-359.68775.23-165.4-300.8

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-174.44-389.68-86.12-813.59-871.02-490.75
Free Cash Flow Growth
------
Free Cash Flow Margin
-13.84%-29.00%-5.65%-67.56%-96.81%-56.79%
Free Cash Flow Per Share
-1.46-3.25-0.72-7.42-8.10-4.57
Levered Free Cash Flow
-336.53-567.63-402.39-1,198-1,165-458.68
Unlevered Free Cash Flow
-331.83-564.55-398.93-1,194-1,165-458.65
Free Cash Flow After Leases
-180.49-394.48-88.44-815.49-872.67-492.52

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
7.524.945.546.291.070.04
Cash Income Tax Paid
41.923.2572.314.930.11115.85
Change in Working Capital
-124.74-156.8829.02-323.43-108.53260.99